Compliance of sildenafil treatment for erectile dysfunction and factors affecting it

Page 1

	Year	Citations
HEALTH OUTCOMES VARIABLES IMPORTANT TO PATIENTS IN THE TREATMENT OF ERECTILE DYSFUNCTION Christine Hanson‐Divers, Sue Ellen Jackson, Tom F. Lue, The Journal of Urology	1998	129
Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra®)? T. Klotz, M.J. Mathers, Rosemarie Klotz, International Journal of Impotence Research UrologyErectile DysfunctionSexual DysfunctionPharmacotherapySex Therapy	2004	80
Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function. Hwancheol Son, Kwanjin Park, Soo-Woong Kim, PubMed	2004	73
Use of Medications for Erectile Dysfunction in the United States, 1996 Through 2001 Diane K. Wysowski, Joslyn Swann The Journal of Urology	2003	28
The Diffusion of a Novel Therapy Into Clinical Practice Leslie R. Harrold, Jerry H. Gurwitz, Terry S. Field, Archives of Internal Medicine	2000	27
What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience B-P Jiann, C-C Yu, Jeng‐Yu Tsai, International Journal of Impotence Research UrologyErectile Dysfunction3-Year Clinical ExperienceSexual DysfunctionMedicine	2003	24
Impact of introduction of sildenafil on other treatment modalities for erectile dysfunction: a study of nationwide and local hospital sales B-P Jiann, C-C Yu, C-C Su International Journal of Impotence Research Sexual HealthUrologyErectile DysfunctionOther Treatment ModalitiesSexual Dysfunction	2004	15

Page 1